TACROLIMUS MONOTHERAPY IN IMMUNOLOGICALLY LOW-RISK KIDNEY TRANSPLANT RECIPIENTS: A RANDOMIZED-CONTROLLED TRIAL

被引：0
|
作者：
de Weerd, Annelies [1 ]
Verschragen, Marieken J. [1 ]
van Gestel, Judith A. [1 ]
Betjes, Michiel G. H. [1 ]
机构：
[1] Erasmus MC, Rotterdam, Netherlands
来源：
TRANSPLANT INTERNATIONAL | 2019年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
LBP049
引用
收藏
页码：417 / 418
页数：2
相关论文
共 50 条
  • [1] TACROLIMUS MONOTHERAPY IN IMMUNOLOGICALLY LOW-RISK KIDNEY TRANSPLANT RECIPIENTS: A RANDOMIZED-CONTROLLED TRIAL
    de Weerd, Annelies
    Boer-Verschragen, Marieken
    Kal-van Gestel, Judith
    Roelen, Dave
    Dieterich, Marjolein
    Betjes, Michiel
    [J]. TRANSPLANT INTERNATIONAL, 2021, 34 : 99 - 100
  • [2] Tacrolimus Monotherapy is Safe in Immunologically Low-Risk Kidney Transplant Recipients: A Randomized-Controlled Pilot Study
    de Weerd, Annelies E.
    Al Fatly, Zainab
    Boer-Verschragen, Marieken
    Kal-van Gestel, Judith A.
    Roelen, Dave L.
    Dieterich, Marjolein
    Betjes, Michiel G. H.
    [J]. TRANSPLANT INTERNATIONAL, 2022, 35
  • [3] A Randomized Controlled Trial on Safety of Steroid Avoidance in Immunologically Low-Risk Kidney Transplant Recipients
    Ekberg, Jana
    Baid-Agrawal, Seema
    Jespersen, Bente
    Kallen, Ragnar
    Rafael, Ehab
    Skov, Karin
    Lindner, Per
    [J]. KIDNEY INTERNATIONAL REPORTS, 2022, 7 (02): : 259 - 269
  • [4] PNEUMOCOCCAL AND TETANUS VACCINATION IN TACROLIMUS TREATED KIDNEY TRANSPLANT RECIPIENTS WITH AND WITHOUT MYCOPHENOLATE MOFETIL: A RANDOMIZED-CONTROLLED TRIAL
    de Weerd, Annelies
    Verschragen, Marieken J.
    van Gestel, Judith A.
    Dik, Wim A.
    Betjes, Michiel
    [J]. TRANSPLANT INTERNATIONAL, 2019, 32 : 417 - 417
  • [5] Randomized controlled trial assessing the impact of everolimus and low-exposure tacrolimus on graft outcomes in kidney transplant recipients
    Taber, David J.
    Chokkalingam, Avudaiappan
    Su, Zemin
    Self, Sally
    Miller, Dylan
    Srinivas, Titte
    [J]. CLINICAL TRANSPLANTATION, 2019, 33 (10)
  • [6] Eculizumab for Chronic Antibody-Mediated Injury in Kidney Transplant Recipients: A Randomized-Controlled Trial.
    Kulkarni, S.
    Kirkiles-Smith, N.
    Deng, Y.
    Formica, R.
    Gilbert, M.
    Broeckner, V.
    Bow, L.
    Pober, J.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 475 - 476
  • [7] Steroid avoidance immunosuppression in low-risk kidney transplant recipients
    Heilman, RL
    Mazur, MJ
    Reddy, KS
    Moss, A
    Post, D
    Mulligan, D
    [J]. TRANSPLANTATION PROCEEDINGS, 2005, 37 (04) : 1785 - 1788
  • [8] A Randomized Controlled Trial of Envarsus Versus Immediate Release Tacrolimus in Kidney Transplant Recipients With Delayed Graft Function
    Parajuli, Sandesh
    Muth, Brenda
    Bloom, Margaret
    Ptak, Lucy
    Aufhauser, David
    Thiessen, Carrie
    Al-Adra, David
    Mezrich, Joshua
    Neidlinger, Nikole
    Odorico, Jon
    Wang, Jacqueline Garonzik
    Foley, David
    Kaufman, Dixon
    Mandelbrot, Didier A.
    [J]. TRANSPLANTATION PROCEEDINGS, 2023, 55 (07) : 1568 - 1574
  • [9] Alemtuzumab preconditioning and tacrolimus monotherapy in pediatric kidney transplant recipients.
    Shapiro, Ron
    Ellis, Demetrius
    Tan, Henkie P.
    Moritz, Michael L.
    Basu, Amit
    Vats, Abhay N.
    Kayler, Liise K.
    Erkan, Elif
    McFeaters, Corde G.
    James, Gerri
    Grosso, Mary J.
    Zeevi, Adriana
    Gray, Edward A.
    Marcos, Amadeo
    Starzl, Thomas E.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 188 - 188
  • [10] Alemtuzumab preconditioning and tacrolimus monotherapy in pediatric kidney transplant recipients.
    Shapiro, Ron
    El Jis, Demetrius
    Tan, Henkie P.
    Tz, Michael L. Mori
    Basu, Amit
    Vats, AbhayN.
    Kayler, Liise K.
    Erkan, Elif
    McFeaters, Corde G.
    James, Gerri
    Grosso, Mary J.
    Zeevi, Adriana
    Gray, Edward A.
    Marcos, Amadeo
    Starzl, Thomas E.
    [J]. PEDIATRIC TRANSPLANTATION, 2007, 11 : 54 - 54
12345